FDA orders 23andMe to cease marketing

On November 22nd the FDA issued an order for the genetics company 23andMe to immediately cease marketing for their home DNA screening kits after several warnings about "misleading claims." The FDA argues that the company "has not analytically or clinically validated the personal genome service for its intended uses." The original FDA letter can be found here, and a CNN article can be found here.